Trials / Completed
CompletedNCT01189851
Intraoperative Radiotherapy for Early Stage Breast Cancer
Intraoperative Radiotherapy (IORT) for the Management of Carcinoma of the Breast: Use of Mammography, Ultrasonography,and Contrast-Enhanced Magnetic Resonance Imaging (CE-MRI) to Identify Candidates for IORT
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Hoag Memorial Hospital Presbyterian · Academic / Other
- Sex
- Female
- Age
- 48 Years
- Healthy volunteers
- Not accepted
Summary
Up to 200 patients with biopsy proven early stage breast cancer selecting Wide Local Excision (WLE) will undergo mammography, ultrasound (of affected breast and ipsilateral axilla) and contrast enhanced-magnetic resonance imaging (CE-MRI) of the affected breast to evaluate the extent of disease.
Detailed description
Patients will be deemed eligible for immediate IORT if the invasive cancer lesion is estimated to measure ≤ 3.0 centimeters maximum dimension by mammogram, ultrasound, and CE-MRI and is thought to be resectable with WLE and clear surgical margins, with clinically staged N0M0 disease, minimum age of 48, and histology of invasive ductal or lobular carcinoma of the breast. The lesion size determined by imaging will be compared with lesion size and surgical margin status obtained from the surgical pathology specimen to evaluate the ability of mammography combined with ultrasound and CE-MRI to identify suitable candidates for immediate IORT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Intraoperative Radiotherapy | The Axxent eBx™ System utilizes a miniaturized high dose rate (HDR) X-ray source to apply radiation directly to the cancerous tumor bed and provides brachytherapy when the physician chooses to deliver intracavitary or interstitial radiation to the surgical margins following lumpectomy for breast cancer. |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2023-09-01
- Completion
- 2023-12-01
- First posted
- 2010-08-27
- Last updated
- 2024-10-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01189851. Inclusion in this directory is not an endorsement.